| Primary |
| Headache |
28.6% |
| Migraine |
28.6% |
| Arthritis |
14.3% |
| Chronic Back Pain |
14.3% |
| Diabetes Mellitus |
14.3% |
|
| Upper Gastrointestinal Haemorrhage |
22.2% |
| Gastrointestinal Disorder |
11.1% |
| Incorrect Dose Administered |
11.1% |
| Potentiating Drug Interaction |
11.1% |
| Pyrexia |
11.1% |
| Underdose |
11.1% |
| Vision Blurred |
11.1% |
| Weight Decreased |
11.1% |
|
| Secondary |
| Pain |
21.3% |
| Headache |
18.1% |
| Migraine |
12.8% |
| Back Pain |
7.4% |
| Product Used For Unknown Indication |
7.4% |
| Drug Use For Unknown Indication |
6.4% |
| Chest Pain |
4.3% |
| Pain In Jaw |
4.3% |
| Sinus Headache |
3.2% |
| Insomnia |
2.1% |
| Jaw Pain |
2.1% |
| Musculoskeletal Pain |
2.1% |
| Arthritis |
1.1% |
| Constipation |
1.1% |
| Diabetes |
1.1% |
| Diabetes Mellitus |
1.1% |
| Dysmenorrhoea |
1.1% |
| Fibromyalgia |
1.1% |
| Pain In Extremity |
1.1% |
| Spinal Pain |
1.1% |
|
| Vision Blurred |
12.0% |
| Drug Hypersensitivity |
8.0% |
| Myocardial Infarction |
8.0% |
| Vomiting |
8.0% |
| Drug Administration Error |
4.0% |
| Drug Ineffective |
4.0% |
| Drug Intolerance |
4.0% |
| Drug Screen Positive |
4.0% |
| Headache |
4.0% |
| Hepatic Enzyme Increased |
4.0% |
| Hepatotoxicity |
4.0% |
| Hospitalisation |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Liver Injury |
4.0% |
| Migraine |
4.0% |
| Oedema |
4.0% |
| Overdose |
4.0% |
| Pain |
4.0% |
| Paraplegia |
4.0% |
| Self-medication |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.0% |
| Drug Use For Unknown Indication |
13.3% |
| Headache |
9.7% |
| Migraine |
8.1% |
| Pain |
5.3% |
| Multiple Sclerosis |
4.6% |
| Depression |
4.4% |
| Hypertension |
2.8% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Contraception |
2.6% |
| Crohn's Disease |
2.5% |
| Arthritis |
2.2% |
| Vitamin Supplementation |
1.8% |
| Arthralgia |
1.7% |
| Anxiety |
1.5% |
| Back Pain |
1.3% |
| Insomnia |
1.3% |
| Psoriasis |
1.3% |
| Hypersensitivity |
1.2% |
|
| Headache |
11.5% |
| Drug Ineffective |
10.7% |
| Vomiting |
8.2% |
| Injection Site Pain |
5.7% |
| Migraine |
5.7% |
| Chronic Lymphocytic Leukaemia |
4.9% |
| Pain |
4.9% |
| Transverse Sinus Thrombosis |
4.9% |
| Urticaria |
4.9% |
| Anal Cancer |
4.1% |
| Arthralgia |
4.1% |
| Nausea |
4.1% |
| Pruritus |
4.1% |
| Weight Decreased |
4.1% |
| Oropharyngeal Pain |
3.3% |
| Sinusitis |
3.3% |
| Treatment Noncompliance |
3.3% |
| Tumour Lysis Syndrome |
3.3% |
| Alopecia |
2.5% |
| Blood Glucose Increased |
2.5% |
|
